Evidence map›Paper›PMID 31243634›Full record

ArticleJournal of biomolecular NMR2019

NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.

Rieko Ishima, Nese Kurt Yilmaz, Celia A Schiffer

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular NMR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Integrative methods in structural biology.Journal of biomolecular NMR · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rieko IshimaDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3418-0922
Nese Kurt YilmazDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-5036-676X
Celia A SchifferDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA. Celia.Schiffer@umassmed.edu.ORCID http://orcid.org/0000-0003-2270-6613
University of Massachusetts Chan Medical School · USUniversity of Pittsburgh · US

Funding

Tracking the evolution of drug resistance for highly potent HIV protease inhibitoP01GM109767 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHERMAN, BRIAN WOODY · 2014 to 2018
$8.0M
NIGMS NIH HHS P01 GM109767
6 · The paper itself

Abstract

Over the last two decades, both the sensitivity of NMR and the time scale of molecular dynamics (MD) simulation have increased tremendously and have advanced the field of protein dynamics. HIV-1 protease has been extensively studied using these two methods, and has presented a framework for cross-evaluation of structural ensembles and internal dynamics by integrating the two methods. Here, we review studies from our laboratories over the last several years, to understand the mechanistic basis of protease drug-resistance mutations and inhibitor responses, using NMR and crystal structure-based parallel MD simulations. Our studies demonstrate that NMR relaxation experiments, together with crystal structures and MD simulations, significantly contributed to the current understanding of structural/dynamic changes due to HIV-1 protease drug resistance mutations.

Indexed as

Molecular Docking SimulationMolecular Dynamics SimulationNuclear Magnetic Resonance, BiomolecularBinding SitesDrug Resistance, ViralHIV ProteaseHIV Protease InhibitorsHumansMutationProtein BindingStructure-Activity RelationshipWaterHIV ProteaseHIV Protease Inhibitorsp16 protease, Human immunodeficiency virus 1WaterCrystal structuresDrug designHIV-1InhibitorMDNMRProtease

Identifiers

PMID31243634
PMCPMC6941145
OpenAlexW2954919163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.